KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Idexx Laboratories (IDXX) Leases (2019 - 2026)

Idexx Laboratories has reported Leases over the past 7 years, most recently at $123.2 million for Q4 2025.

  • For Q4 2025, Leases rose 6.11% year-over-year to $123.2 million; the TTM value through Dec 2025 reached $123.2 million, up 6.11%, while the annual FY2025 figure was $123.2 million, 6.11% up from the prior year.
  • Leases for Q4 2025 was $123.2 million at Idexx Laboratories, down from $128.2 million in the prior quarter.
  • Over five years, Leases peaked at $129.8 million in Q2 2025 and troughed at $93.6 million in Q1 2021.
  • A 5-year average of $114.9 million and a median of $115.7 million in 2023 define the central range for Leases.
  • Biggest five-year swings in Leases: increased 27.08% in 2021 and later dropped 3.24% in 2025.
  • Year by year, Leases stood at $105.1 million in 2021, then increased by 12.86% to $118.6 million in 2022, then fell by 2.63% to $115.5 million in 2023, then increased by 0.55% to $116.1 million in 2024, then grew by 6.11% to $123.2 million in 2025.
  • Business Quant data shows Leases for IDXX at $123.2 million in Q4 2025, $128.2 million in Q3 2025, and $129.8 million in Q2 2025.